NAGE Stock Price, Chart, Stats & News

Niagen Bioscience Inc (NAGE) does not currently pay a dividend.
NAGE chart
Fundamentals
Gross margin | 64.28% |
Operating margin | 11.05% |
Pretax margin | 14.06% |
Net margin | 13.43% |
Effective tax rate | 4.45% |
ROA | 16.34% |
ROE | 26.06% |
D/E | 0.04x |
Interest coverage ratio | – |
NAGE valuation
P/E | 19.81x |
P/S | 2.60x |
P/B | 4.33x |
P/CF | 24.66x |
P/FCF | 25.56x |
P/OCF | 24.66x |
PEG | -1.24x |
EV multiple | 23.93x |
About
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products.
Similar securities
Based on sector and market capitalization





